Last reviewed · How we verify
Adductor canal block with dexamethasone
At a glance
| Generic name | Adductor canal block with dexamethasone |
|---|---|
| Sponsor | University of British Columbia |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty (PHASE4)
- Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block (NA)
- Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks (PHASE1, PHASE2)
- Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA (NA)
- Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty (PHASE4)
- Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery (PHASE4)
- Perineural Dexamethasone in the Adductor Canal Block (NA)
- Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: